Wednesday, July 24, 2019 12:58:11 PM
$LAHO Biotech has outperformed many times over.
year-to-date gain: 559.9 percent
year-to-date gain: 318.97 percent
year-to-date gain: 245.12 percent
https://investingnews.com/daily/life-science-investing/biotech-investing/top-nasdaq-biotech-stocks/
NASDAQ Biotechnology (NBI) long term $196 today $3300.
upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
In a meltup economy (over valuation) invest in Stem's not trends.
$LAHO
year-to-date gain: 559.9 percent
year-to-date gain: 318.97 percent
year-to-date gain: 245.12 percent
https://investingnews.com/daily/life-science-investing/biotech-investing/top-nasdaq-biotech-stocks/
NASDAQ Biotechnology (NBI) long term $196 today $3300.
upsurge in venture capital investment represents growth of 7,300%
https://www.prnewswire.com/news-releases/global-regenerative-medicine-rm-market-report-2019-big-pharma-is-demonstrating-an-interest-in-regenerative-medicine-300872108.html
Drug companies chase deals for cell and gene therapies, biotech's 'next wave'
..$20 billion in mergers and acquisitions
https://www.spglobal.com/marketintelligence/en/news-insights/trending/nATYU0f9Kb7ki7MR_mlO-A2
In a meltup economy (over valuation) invest in Stem's not trends.
$LAHO
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
